Clinical Trial Update: Clinical Study of 18F-FAPI-RGD in Breast Tumors

View source ↗

Summary

The clinical trial evaluating the radiotracer 18F-FAPI-RGD in breast tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 18F-FAPI-RGD (18F-FAPI-RGD)

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: Breast Tumors | Status: COMPLETED